Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Surgeon General's Report on Drug Addiction and Substance Abuse Receives Support from Waismann Method Medical Group

A New Era for Drug Addiction and Drug Treatment

The Waismann Method Group is a forerunner in Advanced Medical Opiate Detoxification and Rapid Detox. The commitment to providing the most effective treatment for opiate dependent patients is just as strong today as it was two decades ago. Our reputation is backed up by 18 years of experience, dedication, and superior care.

News provided by

Waismann Method Medical Group

Nov 28, 2016, 08:30 ET

Share this article

Share toX

Share this article

Share toX

LOS ANGELES, Nov. 28, 2016 /PRNewswire/ -- The United States Surgeon General, Dr. Vivek Murthy, issued the first-ever Surgeon General's report on addiction on Thursday. Dr. Murthy stated that he intends for the report to galvanize support to change drug policy in the United States in the way that a similar report over 50 years ago accelerated efforts to combat smoking. Dr. Michael H. Lowenstein, Medical Director of the Waismann Method Medical Group, supports the Surgeon General's efforts and is enthusiastic about the prospect of changing the way we view and treat substance abuse in the United States.

Continue Reading
The Waismann Method Group is a forerunner in Advanced Medical Opiate Detoxification and Rapid Detox. The commitment to providing the most effective treatment for opiate dependent patients is just as strong today as it was two decades ago. Our reputation is backed up by 18 years of experience, dedication, and superior care.
The Waismann Method Group is a forerunner in Advanced Medical Opiate Detoxification and Rapid Detox. The commitment to providing the most effective treatment for opiate dependent patients is just as strong today as it was two decades ago. Our reputation is backed up by 18 years of experience, dedication, and superior care.

Logo - http://photos.prnewswire.com/prnh/20161123/442678LOGO

Logo - http://photos.prnewswire.com/prnh/20161123/442677LOGO

The report comes at a time when substance abuse issues are ravaging the country. An estimated 20.8 million people in the U.S. are suffering from a substance use disorder. This figure is similar to the number of people who have diabetes and is 150% larger than the number of people who have all types of cancer combined. Additionally, the number of deaths from drug overdose is at an all-time high, with 47,055 deaths in 2014. Unfortunately, the resources devoted to substance abuse lag far behind the government funds allocated to combating these other medical conditions. Despite a commitment from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) to review policies designed to reduce rates of drug addiction, little traction has been gained in the fight against substance abuse.

In the report, entitled "Facing Addiction in America," Dr. Murthy stated clearly that the available scientific evidence indicates that addiction is an illness, not a moral failing. Rather than addiction being a disease of choice or weak willpower, it has become clear that exposure to addictive substances can lead to full-blown addiction in men and women of all ages, ethnicities, and socioeconomic backgrounds. These substances actually change the brain's circuitry, affecting the reward system, stress response, and ability to make decisions. Given this biological basis for addiction, Dr. Murthy is calling for a shift in the way we conceptualize and treat substance abuse.

In response to the Surgeon General's report, Waismann Method Medical Director Dr. Michael Lowenstein stated, "I firmly agree that addiction is a brain-based condition that requires thoughtful, science-based treatment. The vast majority of people in need of addiction treatment do not receive anything that approximates science-based care, and very few treatment providers are medical professionals with the skills, training, and credentials to successfully treat these complex issues. We must treat addiction with the same urgency and compassion that we do with any other medical illness." Dr. Lowenstein continued, "Just 1 in 10 Americans receives the ant treatment for addiction. We can do better than that, and I am excited to be at the forefront of this change in the way we treat and view opiate dependence in America."

The report also reviewed evidence supporting the use of early medical intervention and empirically-supported treatments to combat substance abuse. Several available medical treatments for addiction are supported by scientific evidence, but they remain poorly disseminated to treatment centers. Dr. Murthy's report calls for expanded access to these scientifically-based interventions, allowing patients to benefit from treatments that actually work.

Dr. Murthy's report outlined causes for substance abuse, including overprescribing of opiate painkillers by the nation's physicians. The Surgeon General called for physicians to adhere to new CDC guidelines for prescribing opiates, which is intended to reduce rates of prescription opioid addiction and overdose. The report also advocates for expanded use of prescription drug monitoring programs, which are designed to limit inappropriate prescribing of opioid painkillers.

At the Waismann Method, it is our hope that soon there will no longer be space treatment centers that blame addiction on an individual's character or moral failings. Effective, science-based medical and psychosocial treatments for addiction can replace the shame-based approaches that people suffering from drug abuse have suffered under for years. Additionally, employing treatments supported by scientific evidence has the potential to be more efficacious than treatment-as-usual, resulting in a lower economic and societal cost of drug addiction.

For nearly two decades, the Waismann Method Medical Group has been treating opioid dependence as a medical condition. We operate in an accredited hospital with physicians who have expertise in addiction medicine. The Waismann Method has successfully reversed physical opioid dependence for thousands of patients from all over the world. We also have been trying to change how society views and treats patients who are suffering from drug abuse. At the Waismann Method Medical Group, we believe that addiction is created from a prolonged dependence that is often caused by an underlying, untreated condition that causes high levels of discomfort or distress. By using science-based practices in a medical facility, we can effectively detox patients suffering from opioid dependence and create opportunities for them to combat the issues perpetuating drug addiction.

Media Contact:     
Clare Waismann
[email protected]  
310-205-0808
www.opiates.com

SOURCE Waismann Method Medical Group

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.